Straumann (SAUHF) and Dentsply Sirona (XRAY) Head to Head Analysis

Straumann (OTCMKTS: SAUHF) and Dentsply Sirona (NASDAQ:XRAY) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk.

Valuation and Earnings

How to Become a New Pot Stock Millionaire

This table compares Straumann and Dentsply Sirona’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Straumann $931.55 million 10.89 $233.11 million $12.04 53.04
Dentsply Sirona $3.99 billion 2.79 -$1.55 billion $2.66 18.43

Straumann has higher earnings, but lower revenue than Dentsply Sirona. Dentsply Sirona is trading at a lower price-to-earnings ratio than Straumann, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Straumann and Dentsply Sirona, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Straumann 0 0 0 0 N/A
Dentsply Sirona 1 3 9 0 2.62

Dentsply Sirona has a consensus target price of $67.67, indicating a potential upside of 38.04%. Given Dentsply Sirona’s higher possible upside, analysts clearly believe Dentsply Sirona is more favorable than Straumann.

Profitability

This table compares Straumann and Dentsply Sirona’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Straumann N/A N/A N/A
Dentsply Sirona -39.39% 8.35% 5.61%

Volatility & Risk

Straumann has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500. Comparatively, Dentsply Sirona has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.

Insider & Institutional Ownership

97.8% of Dentsply Sirona shares are owned by institutional investors. 2.0% of Dentsply Sirona shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Dividends

Dentsply Sirona pays an annual dividend of $0.35 per share and has a dividend yield of 0.7%. Straumann does not pay a dividend. Dentsply Sirona pays out 13.2% of its earnings in the form of a dividend.

Summary

Dentsply Sirona beats Straumann on 9 of the 14 factors compared between the two stocks.

Straumann Company Profile

Straumann Holding AG provides tooth replacement solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, biomaterials, and digital solutions for use in tooth replacement and restoration or to prevent tooth loss. The company offers replacement solutions, including soft tissue level and bone level implants; SLActive surface for bone formation; Roxolid for use in dental implantology; and ceramic implants. It also provides prosthetic components and tools, as well as precision instruments, guided surgery tools, and handling components. In addition, the company offers digital solutions, including guided surgery, intra-oral scanning, and CADCAM; and oral tissue regeneration solutions comprising Emdogain, bone substitutes, membranes, soft tissue grafts, and fleeces. Further, it provides training and education services to its customers. The company offers its products to general dentists, specialists, and dental technicians/laboratories in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Dentsply Sirona Company Profile

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply